Comparison Of Keratometric Readings Pre and Post Pterygium Excision With Conjunctival Autograft Transplantation
1 other identifier
interventional
130
1 country
1
Brief Summary
Pterygium, often called "surfer's eye," is a common eye condition in which a raised, fleshy growth of tissue extends from the white part of the eye onto the clear cornea. This growth can cause redness, irritation, blurred vision, and, in advanced cases, changes in the curvature of the cornea leading to distorted vision (astigmatism). The condition is more frequent in people exposed to sunlight, dust, and dry environments. The standard treatment for symptomatic pterygium is surgical removal. However, simple removal has a high chance of recurrence. To reduce this risk, surgeons commonly use a technique called conjunctival autograft transplantation, where a small piece of the patient's own conjunctiva is placed over the area after excision. This method not only lowers the recurrence rate but may also improve vision by reducing corneal irregularities. This study is designed to measure the changes in corneal curvature (keratometric readings) before and after pterygium excision with conjunctival autograft transplantation. By comparing preoperative and postoperative measurements, the study aims to determine how much this surgery improves corneal shape and reduces astigmatism. The hypothesis is that pterygium excision with conjunctival autograft transplantation will lead to a significant improvement in keratometric readings and reduce irregular astigmatism, thereby improving visual quality. This research will provide local evidence of the effectiveness of this procedure and help guide treatment strategies for patients suffering from pterygium-related visual problems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2025
CompletedFirst Submitted
Initial submission to the registry
September 21, 2025
CompletedFirst Posted
Study publicly available on registry
September 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedSeptember 30, 2025
September 1, 2025
6 months
September 21, 2025
September 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Keratometric Readings (K1 and K2)
Keratometric readings, including the flat meridian (K1) and steep meridian (K2) of the anterior corneal surface, will be measured using a manual keratometer. The mean change in K-readings (measured in diopters) from baseline (pre-operative) to post-operative assessment will be calculated to evaluate corneal curvature improvement following pterygium excision with conjunctival autograft.
Baseline (pre-operative) and 1 month post-operative.
Secondary Outcomes (1)
Change in Astigmatism
Baseline (pre-operative) and 1 month post-operative.
Study Arms (1)
Group Pterygium Excision with Conjunctival Autograft
EXPERIMENTALPatients will undergo surgical excision of pterygium followed by conjunctival autograft transplantation. The autograft will be harvested from the superior bulbar conjunctiva and secured at the excision site using sutures.
Interventions
Excision of primary Grade II or Grade III pterygium Conjunctival autograft harvested and transplanted at the excision site Graft secured with sutures
Eligibility Criteria
You may qualify if:
- Adults of either sex aged \>30 to 70 years.
- Phakic eyes.
- Primary pterygium, Grade II or Grade III (as per protocol grading).
- Presence of corneal astigmatism on pre-operative assessment.
- Scheduled for pterygium excision with conjunctival autograft transplantation at the study site.
- Able to provide written informed consent and to attend the 1-month postoperative assessment.
You may not qualify if:
- Pseudophakic or aphakic eyes.
- Recurrent pterygium.
- Prior keratoplasty or trabeculectomy in the study eye.
- Keratoconus or other corneal pathologies that can independently induce astigmatism.
- Lenticular astigmatism or significant lens pathology affecting refraction.
- Eyes planned for simple pterygium excision without conjunctival autograft.
- Any ocular condition or systemic illness judged likely to interfere with keratometric or refractive measurements, follow-up, or surgical safety.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mughal Eye Hospital Trust
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 21, 2025
First Posted
September 30, 2025
Study Start
August 30, 2025
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
September 30, 2025
Record last verified: 2025-09